PIMS (Syndrome inflammatoire multi-systmique pdiatrique li au SARS-CoV-2) _ une nouvelle maladie_ Auteur/autrice de la publication :Admin Publication publiée :29 mars 2021 Post category:COVID 19 PIMS-Syndrome-inflammatoire-multi-systmique-pdiatrique-li-au-SARS-CoV-2-_-une-nouvelle-maladie_Télécharger Vous devriez également aimer Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine_ an interim analysis of a randomised controlled phase 3 trial in Russia 3 février 2021 The inflammatory markers of Multisystem Inflammatory Syndrome in children (MIS‐C) and adolescents associated with COVID‐19_ A Meta‐analysis 22 mars 2021 Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2_ A_nbsp;Systematic Review 14 décembre 2020
Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine_ an interim analysis of a randomised controlled phase 3 trial in Russia 3 février 2021
The inflammatory markers of Multisystem Inflammatory Syndrome in children (MIS‐C) and adolescents associated with COVID‐19_ A Meta‐analysis 22 mars 2021
Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2_ A_nbsp;Systematic Review 14 décembre 2020
